








October 26, 2018
Laurie Goodman, PhD
CEO
ClearLight Biotechnologies, LLC
MMRI Building
428 Oakmead Parkway
Sunnyvale, CA 94085
Re: Amendment #10 to Sponsored Research Agreement (SRA) dated June 10, 2015 and effective July 1, 2015, further modified in Amendment #1 to a start date of July 15, 2015 and modified subsequently as Amendments #2-9
Dear Dr. Goodman:
Pursuant to your recent communication (email attached dated September 19, 2018) in which you notified MMRI of a change of your organization's name, MMRI provides the following amendment in order to accommodate and pursue our research activities. The following modification to our Agreement is presented as Amendment #10.
Effective October I, 2018 it is noted that, ClearLight Diagnostics, LLC is to operate as ClearLight Biotechnologies, LLC.

428 Oakmead Parkway Sunnyvale, CA 94085
Telephone (408) 523-6260 FAX (408) 523-6261

February 9, 2021
Al Hansen
President
Clearlight Biotechnologies, Inc.
MMRI Building
428 Oakmead Parkway
Sunnyvale, CA 94085
Re: Amendment #11 to Sponsored Research Agreement (SRA) dated June 10, 2015 and effective July 1, 2015, further modified in Amendment #1 to a start date of July 15, 2015 and modified subsequently as Amendments #2-10
Dear Mr. Hansen:
Pursuant to your recent communication in which you notified MMRI of a change of your organization's name, MMRI provides the following amendment in order to accommodate and pursue our research activities. The following modification to our Agreement is presented as Amendment #11.
Effective February 9, 2021 it is noted that, ClearLight Biotechnologies, LLC is to operate as Clearlight Biotechnologies, Inc.
Sincerely yours,

Edward P Amento, MD
Executive Director and President
428 Oakmead Parkway Sunnyvale, CA 94085
Telephone (408) 523-6260 FAX (408) 523-6261